Adalimumab as a cause of kidney injury in patients with Crohn's disease

被引：0
|
作者：
Skoczynski, Krzysztof [1 ,2 ]
Koziej, Jan [1 ,2 ]
Szymanska, Sylwia [3 ]
Obrycki, Lukasz [1 ]
Grenda, Ryszard [1 ]
Litwin, Mieczyslaw [1 ,4 ]
机构：
[1] Childrens Mem Hlth Inst, Dept Nephrol Kidney Transplantat & Hypertens, Warsaw, Poland
[2] Cardinal Stefan Wyszynski Univ, Fac Med, Coll Med, Warsaw, Poland
[3] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland
[4] Ctr Continuing Med Educ, Chair Pediat Nephrol, Warsaw, Poland
来源：
PEDIATRIC NEPHROLOGY | 2024年 / 39卷 / 08期
关键词：
Kidney injury; Adalimumab; Drug reaction; Crohn's disease;
D O I：
10.1007/s00467-024-06338-0
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
IntroductionAdalimumab (ADM) is a recombinant human monoclonal antibody (anti-TNF alpha) used to treat inflammatory bowel diseases. It can cause kidney injury (KI).Case diagnosis/treatmentWe describe two pediatric patients with Crohn's disease (CD) in whom ADM therapy was associated with kidney injury (KI). The drug was discontinued in both cases. For the first patient, changes were irreversible despite intensive glucocorticosteroid (GCS) therapy. For the second patient, discontinuation of ADM led to an improvement in kidney function.ConclusionsDue to the risk of KI in patients undergoing ADM therapy, careful assessment of kidney function and early specialist referral are required. Timely withdrawal of ADM can significantly reduce kidney damage, but in some cases, the kidney damage can be irreversible.
引用
收藏
页码：2359 / 2361
页数：3
相关论文
共 50 条
  • [21] Predictors of adalimumab dose escalation in patients with crohn's disease at a tertiary referral center
    Cohen, Russell D.
    Lewis, Jeffrey R.
    Turner, Hannah
    Harrell, Laura E.
    Hanauer, Stephen B.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : 10 - 16
  • [22] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [23] Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease
    Lie, Mitchell R. K. L.
    Kreijne, Joany E.
    van der Woude, C. Janneke
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (01) : 75 - 81
  • [24] Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease
    Veerappan, Sundaram G.
    Healy, Martin
    Walsh, Bernard J.
    O'Morain, Colm A.
    Daly, Jacqueline S.
    Ryan, Barbara M.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (07) : 2119 - 2129
  • [25] Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease
    Sundaram G. Veerappan
    Martin Healy
    Bernard J. Walsh
    Colm A. O’Morain
    Jacqueline S. Daly
    Barbara M. Ryan
    Digestive Diseases and Sciences, 2015, 60 : 2119 - 2129
  • [26] Adalimumab for Crohn's Disease in Clinical Practice at Mayo Clinic: The First 118 Patients
    Swoger, Jason M.
    Loftus, Edward V., Jr.
    Tremaine, William J.
    Faubion, William A.
    Pardi, Darrell S.
    Kane, Sunanda V.
    Hanson, Karen A.
    Harmsen, W. Scott
    Zinsmeister, Alan R.
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (11) : 1912 - 1921
  • [27] Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients
    Mariam Aguas
    Guillermo Bastida
    Elena Cerrillo
    Belén Beltrán
    Marisa Iborra
    Cristina Sánchez-Montes
    Fernando Muoz
    Jesús Barrio
    Sabino Riestra
    Pilar Nos
    World Journal of Gastroenterology, 2012, 18 (32) : 4391 - 4398
  • [28] Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease
    Ogata, Haruhiko
    Watanabe, Mamoru
    Matsui, Toshiyuki
    Hase, Hidenori
    Okayasu, Motohiro
    Tsuchiya, Tsuyoshi
    Shinmura, Yasuhiko
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (09): : 1033 - 1041
  • [29] Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn's Disease?
    Beraldo, Rodrigo Fedatto
    Marcondes, Mariana Barros
    Baima, Julio Pinheiro
    Barros, Jaqueline Ribeiro
    Ramdeen, Madhoor
    Saad-Hossne, Rogerio
    Sassaki, Ligia Yukie
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 293 - 298
  • [30] Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients
    Aguas, Mariam
    Bastida, Guillermo
    Cerrillo, Elena
    Beltran, Belen
    Iborra, Marisa
    Sanchez-Montes, Cristina
    Munoz, Fernando
    Barrio, Jesus
    Riestra, Sabino
    Nos, Pilar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (32) : 4391 - 4398
12345